SCHEMBL4380943

SCHEMBL4380943

CC(C)(C)c1ccc(C=O)c(OCC(=O)O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.61
PTGDR2 Q9Y5Y4 5/20 0.56
SMN1; SMN2 Q16637 3/20 0.54
CD69 Q07108 2/20 0.46
ELANE P08246 1/20 0.46
PSEN1 P49768 1/20 0.43
PSEN2 P49810 1/20 0.43
APH1B Q8WW43 1/20 0.43
NCSTN Q92542 1/20 0.43
APH1A Q96BI3 1/20 0.43
PSENEN Q9NZ42 1/20 0.43
FFAR1 O14842 1/20 0.41
EPHX2 P34913 1/20 0.41
NR1H4 Q96RI1 1/20 0.41
KDM4E B2RXH2 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
POLB P06746 1/20 0.41
GLA P06280 1/20 0.41
NPSR1 Q6W5P4 2/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4642604 0.88 CYP2C19 (0.65) CYP2C19PTGDR2SMN1; SMN2CD69ELANE
SCHEMBL4541506 0.85 CYP2C19 (0.57) CYP2C19PTGDR2SMN1; SMN2CD69ELANE
SCHEMBL13757719 0.83 CYP2C19 (0.74) CYP2C19PTGDR2SMN1; SMN2CD69ELANE
SCHEMBL13580642 0.80 CYP2C19 (0.66) CYP2C19PTGDR2SMN1; SMN2CD69ELANE
SCHEMBL4241015 0.80 PTGDR2 (0.61) CYP2C19PTGDR2SMN1; SMN2PSEN1PSEN2
SCHEMBL13141657 0.79 CYP2C19 (0.64) CYP2C19PTGDR2SMN1; SMN2CD69ELANE
SCHEMBL13624055 0.79 CYP2C19 (0.68) CYP2C19PTGDR2SMN1; SMN2CD69ELANE
SCHEMBL17896571 0.78 CYP2C19 (0.72) CYP2C19PTGDR2SMN1; SMN2CD69ELANE
SCHEMBL5302743 0.78 PTGDR2 (0.63) PTGDR2SMN1; SMN2ELANEPSEN1PSEN2
SCHEMBL7284155 0.78 PTGDR2 (0.63) CYP2C19PTGDR2SMN1; SMN2FFAR1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009081222-A1 SUBSTITUTED TRICYCLIC PYRIDINE OR PYRIMIDINE VANILLOID RECEPTOR LIGANDS GLENMARK PHARMACEUTICALS, S.A. (US) 2009-07-02 WO disclosed